Scientists have identified a way some viruses protect themselves from the immune systems efforts to stop infections, a finding that may make new approaches to treating viral infections possible.
Viruses have well-known strategies for slipping past the immune system. These include faking or stealing a molecular identification badge that prevents a cell from recognizing a virus.
Scientists at Washington University School of Medicine in St. Louis and elsewhere have found some viruses have another trick. They can block the immune system protein that checks for the identification badge.
The blocking structure is called a stem-loop, found at the beginning of the viruss genetic material. This is the first time scientists have found an immune-fighting mechanism built directly into the genetic material of a virus. They are looking for ways to disable it and searching for similar mechanisms that may be built into the genetic material of other disease-causing microorganisms.
When the stem-loop is in place and stable, it blocks a host cell immune protein that otherwise would bind to the virus and stop the infectious process, says senior author Michael Diamond, MD, PhD, professor of medicine. We found that changing a single letter of the viruss genetic code can disable the stem-loops protective effects and allow the virus to be recognized by the host immune protein. We hope to find ways to weaken the stem-loop structure with drugs or other treatments, restoring the natural virus-fighting capabilities of the cell and stopping or slowing some viral infections.
Most life forms encode their genes in DNA. To use the instructions contained in DNA, though, cells have to translate them into a related genetic material, RNA, that can be read by a cells protein-making machinery.
Some viruses encode their genes directly in RNA. Examples include West Nile virus and influenza virus, and the viruses that cause sudden acute respiratory syndrome (SARS), yellow fever and polio.
When a virus infects a cell, it co-opts the cells protein-making machinery to make viral proteins. These proteins allow the virus to replicate. Copies of the virus break into other cells, repeat the process, and the infection spreads.
The researchers studied alphaviruses, a group of RNA viruses that cause fever, encephalitis and infectious arthritis. They showed that a single-letter change in the RNA of an alphavirus strengthened the stem-loop. When the structure was stable, a key immune system protein called Ifit1 was blocked from binding to the viral RNA and the infection continued unchecked. But when the stem-loop was unstable, Ifit1 would bind to the viral RNA and disable it, stopping the infectious process.
Knowing about this built-in viral defense mechanism gives us a new opportunity to improve treatment of infection, Diamond says. To control emergent infections, we must continue to look for ways that viruses have antagonized our natural defense mechanisms and discover how to disable them.
Funding from the National Institutes of Health (NIH) (U19 AI083019 (M.S.D.), R01 AI104972 (M.S.D.), R01 AI083383 (W.B.K.) and Training Grant AI049820 (D.W.T.)), and the Institute for Human Infections and Immunity, University of Texas Medical Branch (S.P.) supported this work. This study made use of the National Magnetic Resonance Facility in Madison, Wis., which is supported by NIH grants P41RR02301 (BRTP/ NCRR) and P41GM66326 (NIGMS).
Source: Washington University in St. Louis
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.